Healios K.K. (OTCMKTS:HLOSF) Short Interest Down 89.6% in November

Healios K.K. (OTCMKTS:HLOSF) was the recipient of a large drop in short interest during the month of November. As of November 30th, there was short interest totalling 500 shares, a drop of 89.6% from the November 15th total of 4,800 shares. Based on an average daily trading volume, of 500 shares, the short-interest ratio is currently 1.0 days.

Healios K.K. Price Performance

HLOSF remained flat at 1.35 during trading on Wednesday. Healios K.K. has a 1-year low of 0.93 and a 1-year high of 1.73. The business has a fifty day simple moving average of 1.46 and a 200-day simple moving average of 1.36.

About Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company offers HLCM051 for treatment of ischemic stroke and acute respiratory distress syndrome; HLCN061 for treating solid tumors; HLCR011 for the treatment of retinal pigment epithelium tear and age-related macular degeneration; and HLCL041 for liver disease.